• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAnixa Biosciences
    Picture of Anixa Biosciences logo

    ANIX — Anixa Biosciences News Story

    $2.990.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapMomentum Trap
    • Market Cap
      $103.94m
    • Enterprise Value
      $88.81m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ANIX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ANIX Dividends
    All News

    NASDAQ RESUMED AT 09:42 AM

    Picture of Anixa Biosciences logoAnixa Biosciences
    14/05/2021 14:42
    NASDAQ RESUMED  ANIX.O  AT 09:42 AM
    

    Recent news on Anixa Biosciences

    See all news
    • Brief: Anixa Biosciences Announces First Case Of Stable Disease For Three Months In Ovarian Cancer Car-T Clinical Trial

      05/10/2026 13:16
    • US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals

      23/09/2026 08:36
    • Anixa Biosciences Inc reports results for the quarter ended July 31 - Earnings Summary

      09/09/2026 21:43
    • Anixa Biosciences Inc expected to post a loss of 9 cents a share - Earnings Preview

      04/09/2026 21:05
    • Factbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine

      19/08/2026 15:46

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.